FDA Approval Process - Search News

Moderna Says FDA Will Consider Its New Flu Shot

FDA to review Moderna's mRNA flu vaccine after initial rejection

Moderna announced that the FDA will review its new mRNA flu vaccine, a reversal less than two weeks after the agency refused to do so. The post FDA to review Moderna's mRNA flu vaccine after initial rejection appeared first on Straight Arrow News.

· 17h · on MSN

FDA's reversal on Moderna flu shot bid followed White House pressure

· 22h

Moderna Says the FDA Will Consider Its New Flu Shot After Resolving a Public Dispute

· 23h

FDA Reverses Course and Will Now Review Moderna’s Flu Shot

The Food and Drug Administration reversed course and agreed to begin a review of Moderna’s MRNA 4.03% application to sell a new seasonal flu shot after the vaccine maker agreed to conduct additional t...

· 23h

F.D.A. Reverses Decision and Agrees to Review Moderna’s Flu Vaccine

· 15h

US FDA reverses course, will review Moderna's flu vaccine application

Yahoo

Changing the FDA’s Vaccine Approval Process Could Threaten COVID, Flu Protection for Children

Add Yahoo as a preferred source to see more of our stories on Google. The U.S. Food and Drug Administration plans to change how COVID vaccines and other shots are approved and administered. The memo, which was written by FDA chief medical and scientific ...

15h

FDA’s abrupt flip-flop on Moderna’s mRNA flu shot highlights growing risks to drug-makers of investing in vaccines

(THE CONVERSATION) The Food and Drug Administration’s decision, made public on Feb. 10, 2026, to not review an application to approve Moderna’s proposed mRNA-based flu vaccine set off a firestorm of criticism from public health experts.

WISN 12 NEWS

FDA official plans to change vaccine approval process

A senior Food and Drug Administration official on Friday said the agency will change its vaccine approval process, alleging that COVID-19 vaccination resulted in the deaths of 10 children.Video above: White House links Tylenol in pregnancy to autism ...

WLKY

FDA to streamline approvals for generic biological drugs in latest move targeting health costs

The U.S. Food and Drug Administration will take steps to streamline the process to develop generic versions of complex biological drugs, the agency announced Wednesday. The changes are meant to accelerate approvals for cheaper alternatives for medications ...